Big Pharma Short Interest Backs Off, With One Huge Exception
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
These five outstanding ideas from Merrill Lynch are decidedly more conservative. Given their strong and consistent dividends, they offer investors excellent total return potential and a safer way to play the stock…
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and Zillow.
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium
The top analyst upgrades, downgrades and initiations seen on Wednesday included CenturyLink, Deere, Ecolab, E*Trade, Merck, Southwest Airlines, S&P, Transocean and Walmart.
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
There are many stocks that are targeted toward mature adults and seniors or that offer classical investing themes for those who are retired now or are within a decade of retiring.
A new addition to the Merrill Lynch US 1 list, plus four additional stocks that offer a fair degree of safety and solid dependable dividends. With the market volatility spiking, it makes…
Merck released better-than-expected fourth-quarter financial results after the markets closed on Thursday.
Merck is scheduled to release its fourth-quarter before the markets open on Friday, and analysts are looking for solid top and bottom line growth.
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this week, including Apple, Exxon and Microsoft.
24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price. We have also added in some additional color on these companies as…
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer, Tesla, Teva Pharmaceutical and Walmart.